GB1230663A
(zh)
|
1968-12-10 |
1971-05-05 |
|
|
GB1356789A
(en)
|
1970-08-06 |
1974-06-12 |
Prodotti Antibiotici Spa |
Derivatives of theophylline
|
DE2050657C3
(de)
|
1970-10-15 |
1974-06-20 |
Basf Ag, 6700 Ludwigshafen |
Azofarbstoffe, Verfahren zu ihrer Herstellung und deren Verwendung
|
US3970753A
(en)
|
1973-06-12 |
1976-07-20 |
Smith Kline & French Laboratories Limited |
Imidazo[1,2-a]pyridines
|
DE2361390A1
(de)
|
1973-12-10 |
1975-06-19 |
Merck Patent Gmbh |
Isochinolinderivate und verfahren zu ihrer herstellung
|
US4246274A
(en)
|
1978-05-10 |
1981-01-20 |
Bayer Aktiengesellschaft |
Antimycotic hydroxypropyl-imidazoles
|
DE2832677A1
(de)
|
1978-07-26 |
1980-02-07 |
Bayer Ag |
Hydroxypropyl-imidazole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
|
DE3210570A1
(de)
|
1982-03-23 |
1983-10-06 |
Hoechst Ag |
3-azolyl-1,2-diaryl-1-halogen-1-propene, ihre herstellung, ihre verwendung als pflanzenschutzmittel und diese verbindungen enthaltende praeparate
|
DE3473442D1
(de)
|
1983-01-21 |
1988-09-22 |
Alkaloida Vegyeszeti Gyar |
New alkyl diamine derivatives
|
DE3650349T2
(de)
|
1985-03-15 |
1995-12-14 |
Antivirals Inc |
Immunotestmittel für polynukleotid und verfahren.
|
DE3628545A1
(de)
|
1985-09-23 |
1987-04-23 |
Hoechst Ag |
Arylmethylazole und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
|
JPH07100688B2
(ja)
|
1986-02-12 |
1995-11-01 |
大日本製薬株式会社 |
環状アミン誘導体
|
CA1317599C
(en)
|
1986-03-26 |
1993-05-11 |
Yukio Nezu |
1,2,6-triphenyl-4(1h)-pyridinone derivatives, production and uses thereof
|
DE3631013A1
(de)
|
1986-09-12 |
1988-03-24 |
Thomae Gmbh Dr K |
Neue naphthylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
DE3879024T2
(de)
|
1987-07-31 |
1993-10-07 |
Takeda Chemical Industries Ltd |
Pyridinium-Derivate, ihre Herstellung und Verwendung.
|
US5179125A
(en)
|
1987-12-03 |
1993-01-12 |
Dainippon Pharmaceutical Co., Ltd. |
N-substituted mercaptopropanamide derivatives
|
US5210266A
(en)
|
1987-12-03 |
1993-05-11 |
Dainippon Pharmaceutical Co., Ltd. |
N-substituted mercaptopropanamide derivatives
|
GB8820231D0
(en)
|
1988-08-25 |
1988-09-28 |
Fujisawa Pharmaceutical Co |
New benzazole compounds processes for preparation thereof & pharmaceutical composition comprising same
|
FR2638747B1
(fr)
|
1988-11-08 |
1993-12-24 |
Synthelabo |
Derives de phenyloxypropanolamines, leur preparation et leur application en therapeutique
|
DE3901723A1
(de)
|
1989-01-21 |
1990-07-26 |
Bayer Ag |
Azolyl-derivate
|
JP2769711B2
(ja)
|
1989-02-17 |
1998-06-25 |
昭和電工株式会社 |
オレフィン重合用触媒成分の製造方法及びオレフィンの重合方法
|
US5229516A
(en)
|
1989-10-27 |
1993-07-20 |
American Home Products Corporation |
Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase
|
US5420289A
(en)
|
1989-10-27 |
1995-05-30 |
American Home Products Corporation |
Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase
|
PT95692A
(pt)
|
1989-10-27 |
1991-09-13 |
American Home Prod |
Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase
|
US5244908A
(en)
|
1990-07-30 |
1993-09-14 |
Takeda Chemical Industries, Ltd. |
Imidazopyridine derivatives and their pharmaceutical use
|
JP3403404B2
(ja)
|
1991-07-03 |
2003-05-06 |
塩野義製薬株式会社 |
ホスホリパーゼa▲2▼阻害物質
|
FI924053A
(fi)
|
1991-09-14 |
1993-03-15 |
Hoechst Ag |
Substituerade aminopropaner, foerfarande foer deras framstaellning och deras anvaendning
|
US5273980A
(en)
|
1991-09-30 |
1993-12-28 |
Merck Frosst Canada Inc. |
Bicyclic-azaarylmethoxy) indoles as inhibitors of leukotriene biosynthesis
|
CA2079374C
(en)
|
1991-09-30 |
2003-08-05 |
Merck Frosst Canada Incorporated |
(bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
|
US5330989A
(en)
|
1991-10-24 |
1994-07-19 |
American Home Products Corporation |
Heterocycles substituted with biphenyl-3-cyclobutene-1,2-dione derivatives
|
AU2945392A
(en)
|
1991-12-10 |
1993-07-19 |
Hoechst Schering Agrevo Gmbh |
Pyrimidinyl- or triazinyl-oxy(or thio)aldehyde derivatives and their use as herbicides or plant-growth regulators
|
GB9206757D0
(en)
|
1992-03-27 |
1992-05-13 |
Ferring Bv |
Novel peptide receptor ligands
|
DE4227522A1
(de)
|
1992-08-20 |
1994-02-24 |
Bayer Ag |
Lichtpolarisierende Folien und neue dichroitische Farbstoffe hierfür
|
JP3298954B2
(ja)
|
1992-12-16 |
2002-07-08 |
三共株式会社 |
新規n,n’−ジベンゾイルヒドラジン誘導体及び殺虫組成物
|
US5484926A
(en)
|
1993-10-07 |
1996-01-16 |
Agouron Pharmaceuticals, Inc. |
HIV protease inhibitors
|
EP0825184B1
(en)
|
1993-03-29 |
2001-06-20 |
AstraZeneca AB |
Heterocyclic derivatives as platelet aggregation inhibitors
|
IL109220A0
(en)
|
1993-04-05 |
1994-07-31 |
Synaptic Pharma Corp |
Dihydropyridines and new uses thereof
|
WO1994027971A1
(en)
|
1993-05-27 |
1994-12-08 |
Smithkline Beecham Laboratoires Pharmaceutiques |
Anti-arrhythmic n-substituted 3-benzazepines or isoquinolines
|
FR2706895A1
(en)
|
1993-06-22 |
1994-12-30 |
Synthelabo |
Tetrahydroisoquinoline derivatives, their preparation and their application in therapeutics
|
JPH07179402A
(ja)
|
1993-10-20 |
1995-07-18 |
Ishihara Sangyo Kaisha Ltd |
置換ベンゼン誘導体、その製造方法及びそれを含有する有害生物防除剤
|
US5461154A
(en)
|
1994-02-02 |
1995-10-24 |
Eli Lilly And Company |
Intermediate and process for making
|
TW281667B
(zh)
|
1994-02-03 |
1996-07-21 |
Synthelabo |
|
GB9402807D0
(en)
|
1994-02-14 |
1994-04-06 |
Xenova Ltd |
Pharmaceutical compounds
|
JPH07304770A
(ja)
|
1994-05-11 |
1995-11-21 |
Kanebo Ltd |
新規ベンゾアゼピノン誘導体
|
US5593994A
(en)
|
1994-09-29 |
1997-01-14 |
The Dupont Merck Pharmaceutical Company |
Prostaglandin synthase inhibitors
|
BR9509760A
(pt)
|
1994-11-23 |
1998-06-30 |
Neurogen Corp |
Composto
|
US5541033A
(en)
|
1995-02-01 |
1996-07-30 |
Ocg Microelectronic Materials, Inc. |
Selected o-quinonediazide sulfonic acid esters of phenolic compounds and their use in radiation-sensitive compositions
|
US5554621A
(en)
|
1995-06-07 |
1996-09-10 |
Bristol-Myers Squibb Company |
Dihydropyridine NPY antagonists: nitrogen heterocyclic derivatives
|
US20030018025A1
(en)
|
1995-06-07 |
2003-01-23 |
Neurogen Corporation, Corporation Of The State Of Delaware |
Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives: new classes of dopamine receptor subtype specific ligands
|
EP0848957A1
(en)
|
1995-09-08 |
1998-06-24 |
Kanebo Ltd. |
Fas LIGAND SOLUBILIZATION INHIBITOR
|
ZA967892B
(en)
|
1995-09-21 |
1998-03-18 |
Lilly Co Eli |
Selective β3 adrenergic agonists.
|
WO1997024119A1
(en)
|
1995-12-29 |
1997-07-10 |
Smithkline Beecham Corporation |
Vitronectin receptor antagonists
|
AU2404897A
(en)
|
1996-04-24 |
1997-11-12 |
Takeda Chemical Industries Ltd. |
Fused imidazopyridine derivatives as antihyperlipidemic agents
|
ATE353937T1
(de)
|
1996-07-17 |
2007-03-15 |
Fuji Photo Film Co Ltd |
Verfahren zur synthese einer oxonolverbindung
|
GB9717576D0
(en)
|
1997-08-19 |
1997-10-22 |
Xenova Ltd |
Pharmaceutical compounds
|
HN1997000027A
(es)
|
1996-12-06 |
1997-06-05 |
Pfizer Prod Inc |
Derivados de 6-fenil piridil - 2 amina
|
HUP9700392A1
(hu)
|
1997-02-10 |
1999-09-28 |
ICN Magyarország Részvénytársaság |
Egy vagy két hatóanyagot tartalmazó kardioprotektív hatású gyógyszerkészítmények
|
US6048877A
(en)
|
1997-02-21 |
2000-04-11 |
Bristol-Myers Squibb Company |
Tetralone derivatives as antiarrhythmic agents
|
ATE390404T1
(de)
|
1997-02-27 |
2008-04-15 |
Takeda Pharmaceutical |
Aminderivate, ihre herstellung und verwendung als inhibitoren der produktion von amyloid-beta
|
DE19717371A1
(de)
|
1997-04-24 |
1998-10-29 |
Basf Ag |
Propargyl-terminierte, nematische oder cholesterische Polymere
|
AU745839B2
(en)
|
1997-07-31 |
2002-04-11 |
F. Hoffmann-La Roche Ag |
O-substituted hydroxycumaranone derivatives as antitumor and antimetastatic agents
|
JPH11119379A
(ja)
|
1997-10-08 |
1999-04-30 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラー写真感光材料および画像形成方法
|
AU3352899A
(en)
|
1997-12-11 |
1999-07-12 |
American Home Products Corporation |
2,4,6-trisubstituted pyridines with estrogenic activity and methods for the solid phase synthesis thereof
|
TW555757B
(en)
|
1998-07-31 |
2003-10-01 |
Akzo Nobel Nv |
Aminomethylcarboxylic acid derivatives
|
DE19834751A1
(de)
|
1998-08-01 |
2000-02-03 |
Boehringer Ingelheim Pharma |
Disubstituierte bicyclische Heterocyclen, ihre Herstellung und ihre Verwendung als Arzneimittel
|
WO2000023420A1
(fr)
|
1998-10-20 |
2000-04-27 |
Takeda Chemical Industries, Ltd. |
Derives d'amine aromatique, procede de preparation de ces derives et agents les contenant
|
GB9823873D0
(en)
|
1998-10-30 |
1998-12-30 |
Pharmacia & Upjohn Spa |
2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
|
JP4603679B2
(ja)
|
1999-12-14 |
2010-12-22 |
日本化薬株式会社 |
害虫防除剤
|
GB0007108D0
(en)
|
2000-03-23 |
2000-05-17 |
Novartis Ag |
Organic compounds
|
US6534651B2
(en)
|
2000-04-06 |
2003-03-18 |
Inotek Pharmaceuticals Corp. |
7-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereof
|
AU2001258771A1
(en)
|
2000-05-19 |
2001-11-26 |
Takeda Chemical Industries Ltd. |
-secretase inhibitors
|
ATE302751T1
(de)
|
2000-06-30 |
2005-09-15 |
Elan Pharm Inc |
Verbindungen zur behandlung der alzheimerischen krankheit
|
US6846813B2
(en)
|
2000-06-30 |
2005-01-25 |
Pharmacia & Upjohn Company |
Compounds to treat alzheimer's disease
|
WO2002034716A2
(en)
|
2000-10-11 |
2002-05-02 |
Merck & Co., Inc. |
Pyrrolidine modulators of ccr5 chemokine receptor activity
|
US20020094989A1
(en)
|
2000-10-11 |
2002-07-18 |
Hale Jeffrey J. |
Pyrrolidine modulators of CCR5 chemokine receptor activity
|
SE0100568D0
(sv)
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
Compounds
|
DE10110750A1
(de)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
FR2822153B1
(fr)
|
2001-03-19 |
2003-10-31 |
Servier Lab |
Nouveaux derives d'indenoindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
IL157093A0
(en)
|
2001-03-27 |
2004-02-08 |
Actelion Pharmaceuticals Ltd |
1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
|
FR2822827B1
(fr)
|
2001-03-28 |
2003-05-16 |
Sanofi Synthelabo |
Nouveaux derives de n-(arylsulfonyl) beta-aminoacides comportant un groupe aminomethyle substitue, leur procede de preparation et les compositions pharmaceutiques en contenant
|
CA2443868C
(en)
|
2001-04-10 |
2011-01-25 |
Ortho-Mcneil Pharmaceutical, Inc. |
1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders
|
WO2002088089A1
(fr)
|
2001-04-19 |
2002-11-07 |
Banyu Pharmaceutical Co., Ltd. |
Derives de spiropiperidine, antagonistes du recepteur de nociceptine les contenant en tant qu'ingredient actif et compositions medicinales
|
ES2269709T3
(es)
|
2001-06-05 |
2007-04-01 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Compuestos de cicloalquil-urea, fusionada con grupos benzo y 1,4-disustituida.
|
PL368051A1
(en)
|
2001-06-07 |
2005-03-21 |
Eli Lilly And Company |
Modulators of peroxisome proliferator activated receptors
|
BR0212676A
(pt)
*
|
2001-09-21 |
2006-05-23 |
Upjohn Co |
compostos terapêuticos ligantes de 5-ht, composições farmacêuticas compreendendo tais compostos e seus usos
|
US7232819B2
(en)
|
2001-10-26 |
2007-06-19 |
Istituto Di Ricerche Di Biologia P. Angeletti S.P.A. |
Dihydroxypyrimidine carboxamide inhibitors of HIV integrase
|
SE0103644D0
(sv)
|
2001-11-01 |
2001-11-01 |
Astrazeneca Ab |
Therapeutic isoquinoline compounds
|
DE60225174T2
(de)
|
2001-11-20 |
2009-02-12 |
Eli Lilly And Co., Indianapolis |
Beta-3 adrenergische agonisten
|
WO2003044016A1
(en)
|
2001-11-20 |
2003-05-30 |
Eli Lilly And Company |
3-SUBSTITUTED OXINDOLE β3 AGONISTS
|
GB0202873D0
(en)
|
2002-02-07 |
2002-03-27 |
Novartis Ag |
Organic compounds
|
US6875780B2
(en)
|
2002-04-05 |
2005-04-05 |
Warner-Lambert Company |
Compounds that modulate PPAR activity and methods for their preparation
|
WO2004011430A1
(ja)
|
2002-07-25 |
2004-02-05 |
Yamanouchi Pharmaceutical Co., Ltd. |
ナトリウムチャネル阻害剤
|
EP1388342A1
(en)
|
2002-08-07 |
2004-02-11 |
Aventis Pharma Deutschland GmbH |
Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
|
MXPA05002622A
(es)
|
2002-09-09 |
2005-09-08 |
Johnson & Johnson |
Derivados de 1,3,8,-triazaespiro [4.5]decan-4-ona sustituidos con hidroxialquilo utiles para el tratamiento de desordenes mediados por el receptor opioide huerfano.
|
AU2003271185A1
(en)
|
2002-10-15 |
2004-05-04 |
Takeda Pharmaceutical Company Limited |
Imidazopyridine derivative, process for producing the same, and use
|
AU2003284596A1
(en)
|
2002-11-22 |
2004-06-18 |
Takeda Pharmaceutical Company Limited |
Imidazole derivative, process for producing the same, and use
|
WO2004052846A1
(en)
|
2002-12-06 |
2004-06-24 |
Bayer Healthcare Ag |
Tetrahydro-naphthalene derivatives
|
JP2006511587A
(ja)
|
2002-12-20 |
2006-04-06 |
ミジェニックス コーポレイション |
アデニンヌクレオチドトランスロカーゼ(ant)リガンドならびにそれに関連する組成物および方法
|
EP1947102A1
(en)
|
2003-01-09 |
2008-07-23 |
Pfizer, Inc. |
Compositions comprising diazepinoindole derivatives as kinase inhibitors
|
WO2004078731A1
(fr)
|
2003-03-06 |
2004-09-16 |
'chemical Diversity Research Institute', Ltd. |
Acides quinoline-carboxyliques et leurs derives et bibliotheque focalisee
|
EP1611483A4
(en)
|
2003-03-11 |
2009-12-16 |
Fujifilm Electronic Materials |
NEW PHOTOSENSITIVE RESIN COMPOSITIONS
|
GB0309221D0
(en)
*
|
2003-04-23 |
2003-06-04 |
Glaxo Group Ltd |
Novel compounds
|
JP2005060247A
(ja)
|
2003-08-12 |
2005-03-10 |
Takeda Chem Ind Ltd |
イソキノリノン誘導体、その製造法および用途
|
US7504401B2
(en)
|
2003-08-29 |
2009-03-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
US7820673B2
(en)
|
2003-12-17 |
2010-10-26 |
Takeda Pharmaceutical Company Limited |
Urea derivative, process for producing the same, and use
|
US20050159334A1
(en)
|
2004-01-16 |
2005-07-21 |
Gluck Oscar S. |
Method for treating rheumatoid arthritis by inhibiting peptidylarginine deiminase
|
JP5319113B2
(ja)
|
2004-03-26 |
2013-10-16 |
メチルジーン インコーポレイテッド |
ヒストンデアセチラーゼの阻害剤
|
TWI351282B
(en)
|
2004-04-07 |
2011-11-01 |
Theravance Inc |
Quinolinone-carboxamide compounds as 5-ht4 recepto
|
RU2266906C1
(ru)
|
2004-04-29 |
2005-12-27 |
Общество с ограниченной ответственностью "Исследовательский Институт Химического Разнообразия" (ООО "Исследовательский Институт Химического Разнообразия") |
Анелированные карбамоилазагетероциклы, способы их получения (варианты), фармацевтическая композиция, фокусированная библиотека
|
GB0413605D0
(en)
|
2004-06-17 |
2004-07-21 |
Addex Pharmaceuticals Sa |
Novel compounds
|
US7488745B2
(en)
|
2004-07-16 |
2009-02-10 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders
|
EP1655283A1
(en)
|
2004-11-08 |
2006-05-10 |
Evotec OAI AG |
11beta-HSD1 Inhibitors
|
JP2008007405A
(ja)
|
2004-12-07 |
2008-01-17 |
Takeda Chem Ind Ltd |
カルボキサミド誘導体
|
US7419989B2
(en)
|
2004-12-22 |
2008-09-02 |
Theravance, Inc. |
Indazole-carboxamide compounds
|
US7402596B2
(en)
|
2005-03-24 |
2008-07-22 |
Renovis, Inc. |
Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
|
DE102005016547A1
(de)
|
2005-04-08 |
2006-10-12 |
Grünenthal GmbH |
Substituierte 5,6,7,8-Tetrahydro-imidazo(1,2-a)pyridin-2-ylamin-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
|
CA2609053C
(en)
|
2005-05-17 |
2017-04-25 |
Sarcode Corporation |
Compositions and methods for treatment of eye disorders
|
AR054363A1
(es)
|
2005-05-23 |
2007-06-20 |
Astrazeneca Ab |
Compuestos que exhiben actividad moduladora en el receptor 5-hidroxi-triptamina 6
|
US7649115B2
(en)
|
2005-06-02 |
2010-01-19 |
Jenrin Discovery, Inc. |
MAO-B inhibitors useful for treating obesity
|
JP5086248B2
(ja)
|
2005-06-07 |
2012-11-28 |
セラヴァンス, インコーポレーテッド |
5−ht4受容体アゴニストとしてのベンゾイミダゾロン−カルボキサミド化合物
|
US7592461B2
(en)
|
2005-12-21 |
2009-09-22 |
Bristol-Myers Squibb Company |
Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
|
EP1984375A2
(en)
|
2006-01-25 |
2008-10-29 |
Smithkline Beecham Corporation |
Chemical compounds
|
US20070191371A1
(en)
|
2006-02-14 |
2007-08-16 |
Kalypsys, Inc. |
Heterocyclic modulators of ppar
|
WO2007106469A2
(en)
|
2006-03-14 |
2007-09-20 |
Amgen Inc. |
Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
|
RU2302417C1
(ru)
|
2006-03-14 |
2007-07-10 |
Иващенко Андрей Александрович |
1-оксо-3-(1н-индол-3-ил)-1,2,3,4-тетрагидроизохинолины, способы их получения, комбинаторная библиотека и фокусированная библиотека
|
RU2303597C1
(ru)
|
2006-05-12 |
2007-07-27 |
Иващенко Андрей Александрович |
Фармацевтическая композиция, способы ее получения и применения
|
US20080280891A1
(en)
|
2006-06-27 |
2008-11-13 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
JP5352454B2
(ja)
|
2006-06-28 |
2013-11-27 |
サノフイ |
Cxcr2アンンタゴニスト
|
WO2008008059A1
(en)
|
2006-07-12 |
2008-01-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents ans uses thereof
|
DE102006039003A1
(de)
|
2006-08-19 |
2008-02-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Verbindungen
|
CN101528744A
(zh)
|
2006-10-20 |
2009-09-09 |
Irm责任有限公司 |
用于调节c-kit和pdgfr受体的组合物和方法
|
JP2010510250A
(ja)
|
2006-11-21 |
2010-04-02 |
ユニバーシティ オブ バージニア パテント ファンデーション |
スフィンゴシン=1−燐酸受容体アゴニスト活性を有するヒドリンダンアナログ
|
CA2670636A1
(en)
|
2006-11-27 |
2008-06-05 |
H. Lundbeck A/S |
Heteroaryl amide derivatives
|
WO2008065500A2
(en)
|
2006-11-30 |
2008-06-05 |
Pfizer Products Inc. |
Heteroaryl amides as type i glycine transport inhibitors
|
CN101652352A
(zh)
|
2006-12-22 |
2010-02-17 |
诺瓦提斯公司 |
用于抑制pdk1的喹唑啉类
|
EP2137158A4
(en)
|
2007-02-28 |
2012-04-18 |
Methylgene Inc |
LOW-MOLECULAR INHIBITORS OF PROTEINARGININE METHYLTRANSFERASES (PRMTS)
|
US8586619B2
(en)
|
2007-03-12 |
2013-11-19 |
Vm Therapeutics Llc |
Agents of calcium ion channel modulators
|
JP2010522765A
(ja)
|
2007-03-28 |
2010-07-08 |
アレイ バイオファーマ、インコーポレイテッド |
受容体チロシンキナーゼとしてのイミダゾ[1,2−a]ピリジン化合物
|
US8273766B2
(en)
|
2007-04-04 |
2012-09-25 |
Kowa Company, Ltd. |
Tetrahydroisoquinoline compound
|
JP2008280344A
(ja)
|
2007-04-12 |
2008-11-20 |
Sumitomo Chemical Co Ltd |
ヒドラジド化合物及びそれを含有する有害節足動物防除剤
|
TW200902533A
(en)
|
2007-05-02 |
2009-01-16 |
Boehringer Ingelheim Int |
Carboxylic acid amides, manufacturing and use thereof as medicaments
|
CA2692004C
(en)
|
2007-06-15 |
2013-04-09 |
Board Of Regents, The University Of Texas System |
Methods and compositions to inhibit edema factor and adenylyl cyclase
|
AU2008264458B2
(en)
|
2007-06-20 |
2013-01-24 |
Mitsubishi Tanabe Pharma Corporation |
Novel malonic acid sulfonamide derivative and pharmaceutical use thereof
|
RU2345996C1
(ru)
|
2007-07-17 |
2009-02-10 |
Андрей Александрович Иващенко |
Аннелированные азагетероциклические амиды, включающие пиримидиновый фрагмент, способ их получения и применения
|
JP2010535773A
(ja)
|
2007-08-10 |
2010-11-25 |
グラクソスミスクライン エルエルシー |
ウイルス感染を治療するための窒素含有二環式化学物質
|
TW200922468A
(en)
|
2007-10-11 |
2009-06-01 |
Sumitomo Chemical Co |
α, β-unsaturated imine compound and use thereof for pest control
|
EP3797775A1
(en)
|
2007-10-19 |
2021-03-31 |
Novartis AG |
Compositions and methods for treatment of diabetic retinopathy
|
CA2709784A1
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
EP2072050A1
(en)
|
2007-12-21 |
2009-06-24 |
Santhera Pharmaceuticals (Schweiz) AG |
Compounds with anti-emetic effect
|
FR2925902B1
(fr)
|
2008-01-02 |
2011-01-07 |
Sanofi Aventis |
DERIVES D'IMIDAZO°1,2-a!PYRIDINE-2-CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
|
RU2371444C1
(ru)
|
2008-01-24 |
2009-10-27 |
Андрей Александрович Иващенко |
ФУРО- И ТИЕНО[2,3-b]-ХИНОЛИН-2-КАРБОКСАМИДЫ, СПОСОБ ПОЛУЧЕНИЯ И ПРОТИВОТУБЕРКУЛЕЗНАЯ АКТИВНОСТЬ
|
MX2010009269A
(es)
|
2008-02-22 |
2010-09-14 |
Otsuka Pharma Co Ltd |
Compuesto de benzodiazepina y composicion farmaceutica.
|
JP2009209090A
(ja)
|
2008-03-04 |
2009-09-17 |
Mitsui Chemicals Inc |
殺虫剤及び該殺虫剤に含まれる化合物、並びに該化合物の使用方法
|
US20090276250A1
(en)
|
2008-05-01 |
2009-11-05 |
Travel Tech Systems, Llc |
Process and system to determine commercial airline arrivals
|
US8148408B2
(en)
|
2008-05-09 |
2012-04-03 |
Abbott Laboratories |
Selective substituted pyridine ligands for neuronal nicotinic receptors
|
WO2009140101A2
(en)
|
2008-05-12 |
2009-11-19 |
Boehringer Ingelheim International Gmbh |
Imidazopyridine compounds useful as mmp-13 inhibitors
|
JP2009274984A
(ja)
|
2008-05-14 |
2009-11-26 |
Sumitomo Chemical Co Ltd |
化合物、光学フィルムおよび光学フィルムの製造方法
|
US20100121052A1
(en)
|
2008-06-20 |
2010-05-13 |
Rama Jain |
Novel compounds for treating proliferative diseases
|
KR20110082145A
(ko)
|
2008-10-21 |
2011-07-18 |
메타볼렉스, 인코포레이티드 |
아릴 gpr120 수용체 작동약 및 이의 용도
|
DE102008060958A1
(de)
|
2008-12-06 |
2010-07-08 |
Saltigo Gmbh |
Hydroxytetralone
|
US9040508B2
(en)
|
2008-12-08 |
2015-05-26 |
Vm Pharma Llc |
Compositions of protein receptor tyrosine kinase inhibitors
|
US8367700B2
(en)
|
2008-12-17 |
2013-02-05 |
Gruenenthal Gmbh |
Substituted 4-(1.2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators
|
US20100204265A1
(en)
|
2009-02-09 |
2010-08-12 |
Genelabs Technologies, Inc. |
Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections
|
JP2012051806A
(ja)
|
2009-02-26 |
2012-03-15 |
Eisai R & D Management Co Ltd |
イミダゾリルピラジン誘導体
|
TWI482769B
(zh)
|
2009-03-16 |
2015-05-01 |
Sumitomo Chemical Co |
化合物、光學膜片及光學膜片之製造方法
|
JP5899607B2
(ja)
|
2009-03-16 |
2016-04-06 |
住友化学株式会社 |
化合物、光学フィルム及び光学フィルムの製造方法
|
US8410144B2
(en)
|
2009-03-31 |
2013-04-02 |
Arqule, Inc. |
Substituted indolo-pyridinone compounds
|
US20110077250A1
(en)
|
2009-06-26 |
2011-03-31 |
Ryder Sean |
Compounds for modulating rna binding proteins and uses therefor
|
JP5669481B2
(ja)
|
2009-08-21 |
2015-02-12 |
大塚製薬株式会社 |
医薬組成物
|
GB0914767D0
(en)
|
2009-08-24 |
2009-09-30 |
Sterix Ltd |
Compound
|
EP2357176A1
(en)
|
2010-01-15 |
2011-08-17 |
Hybrigenics S.A. |
Amidoacridine derivatives useful as selective inhibitors of ubiquitin specific protease 7
|
NZ717149A
(en)
|
2010-02-11 |
2017-06-30 |
Celgene Corp |
Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same for treating various diseases
|
UY33304A
(es)
|
2010-04-02 |
2011-10-31 |
Amgen Inc |
Compuestos heterocíclicos y sus usos
|
US9079880B2
(en)
|
2010-07-07 |
2015-07-14 |
Boehringer Ingelheim International Gmbh |
Rho kinase inhibitors
|
US8697911B2
(en)
|
2010-07-07 |
2014-04-15 |
Boehringer Ingelheim International Gmbh |
Rho kinase inhibitors
|
WO2012022045A1
(en)
|
2010-08-20 |
2012-02-23 |
Hutchison Medipharma Limited |
Pyrrolopyrimidine compounds and uses thereof
|
MX2013001970A
(es)
|
2010-08-20 |
2013-08-09 |
Hutchison Medipharma Ltd |
Compuestos de pirrolopirimidina y usos de los mismos.
|
EP2632461A4
(en)
|
2010-10-29 |
2014-04-02 |
Merck Sharp & Dohme |
ISOINDOLINONE COMPOUNDS USEFUL AS PDE INHIBITORS 10
|
WO2012087833A1
(en)
|
2010-12-22 |
2012-06-28 |
Abbott Laboratories |
Hepatitis c inhibitors and uses thereof
|
WO2013002879A1
(en)
|
2011-06-29 |
2013-01-03 |
President And Fellows Of Harvard College |
Small molecule cd38 inhibitors and methods of using same
|
CA2847292A1
(en)
|
2011-06-29 |
2013-01-03 |
The General Hospital Corporation |
Compositions and methods for enhancing bioenergetic status in female germ cells
|
US9938269B2
(en)
|
2011-06-30 |
2018-04-10 |
Abbvie Inc. |
Inhibitor compounds of phosphodiesterase type 10A
|
JP2014198669A
(ja)
|
2011-08-03 |
2014-10-23 |
杏林製薬株式会社 |
ビアリールエステル誘導体、及びそれらを有効成分とする医薬
|
CN104066729A
(zh)
|
2011-08-15 |
2014-09-24 |
英特穆恩公司 |
溶血磷脂酸受体拮抗剂
|
US20130116241A1
(en)
|
2011-11-09 |
2013-05-09 |
Abbvie Inc. |
Novel inhibitor compounds of phosphodiesterase type 10a
|
EP2794611B1
(en)
|
2011-12-22 |
2017-10-11 |
Gilead Sciences, Inc. |
Pyrazolo[1,5-a]pyrimidines as antiviral agents
|
CA2859869A1
(en)
|
2011-12-23 |
2013-06-27 |
Novartis Ag |
Compounds for inhibiting the interaction of bcl2 with binding partners
|
MX2014007731A
(es)
|
2011-12-23 |
2015-01-12 |
Novartis Ag |
Compuestos para inhibir la interaccion de bcl2 con los componentes de enlace.
|
US9126980B2
(en)
|
2011-12-23 |
2015-09-08 |
Novartis Ag |
Compounds for inhibiting the interaction of BCL2 with binding partners
|
BR112014015308A2
(pt)
|
2011-12-23 |
2017-06-13 |
Novartis Ag |
compostos para inibição da interação de bcl2 com contrapartes de ligação
|
CZ2012114A3
(cs)
|
2012-02-17 |
2013-02-20 |
Zentiva, K.S. |
Zpusob prípravy rivaroxabanu zalozený na úspore 1,1´ -karbonyldiimidazolu
|
US8859541B2
(en)
|
2012-02-27 |
2014-10-14 |
Boehringer Ingelheim International Gmbh |
6-alkynylpyridines
|
WO2013174895A1
(en)
|
2012-05-24 |
2013-11-28 |
Cellzome Limited |
Heterocyclyl pyrimidine analogues as tyk2 inhibitors
|
EP2669276A1
(en)
|
2012-05-31 |
2013-12-04 |
Université de Strasbourg |
Ornithine- and lysine-derivatives for the treatment of pain
|
CA2877301A1
(en)
|
2012-06-20 |
2013-12-27 |
Michael J. Heller |
Dynamic biomimetic synzyme catalyst, catalysis, and catalytic systems
|
FR2993564B1
(fr)
|
2012-07-20 |
2014-08-22 |
Metabrain Res |
Derives d'imidazopyridine utiles dans le traitement du diabete
|
HUE033294T2
(en)
*
|
2012-07-26 |
2017-11-28 |
Glaxo Group Ltd |
2- (azaindol-2-yl) benzimidazoles as PAD4 inhibitors
|
WO2014031872A2
(en)
|
2012-08-23 |
2014-02-27 |
The Broad Institute, Inc. |
Small molecule inhibitors for treating parasitic infections
|
AU2013305591B2
(en)
|
2012-08-24 |
2017-04-13 |
Board Of Regents Of The University Of Texas System |
Pro-neurogenic compounds
|
EP2921229A1
(en)
|
2012-11-15 |
2015-09-23 |
Takasago International Corporation |
Aluminum catalyst
|
JP2016511744A
(ja)
|
2012-12-21 |
2016-04-21 |
エピザイム,インコーポレイティド |
Prmt5を阻害する方法
|
PT2935222T
(pt)
|
2012-12-21 |
2018-12-10 |
Epizyme Inc |
Inibidores de prmt5 e seus usos
|
EP2968303B1
(en)
|
2013-03-14 |
2018-07-04 |
The Trustees of Columbia University in the City of New York |
Octahydrocyclopentapyrroles, their preparation and use
|
FR3008976A1
(fr)
|
2013-07-23 |
2015-01-30 |
Servier Lab |
"nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent"
|
MX2016002075A
(es)
|
2013-08-27 |
2016-05-26 |
Squibb Bristol Myers Co |
Inhibidores de indolamina 2,3-dioxigenasa (ido).
|
CA2923184A1
(en)
|
2013-09-04 |
2015-03-12 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
GB201321730D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
GB201321746D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
WO2015108038A1
(ja)
|
2014-01-17 |
2015-07-23 |
第一三共株式会社 |
エチレングリコール化合物
|
TW201540711A
(zh)
|
2014-02-27 |
2015-11-01 |
Ono Pharmaceutical Co |
具有選擇性ep2促效劑活性的化合物
|
US9067898B1
(en)
|
2014-03-07 |
2015-06-30 |
Janssen Pharmaceutica Nv |
Isothiazole derivatives as GPR120 agonists for the treatment of type II diabetes
|
JP6535022B2
(ja)
|
2014-03-19 |
2019-06-26 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ヘテロアリールsyk阻害剤
|
WO2015197028A1
(en)
|
2014-06-28 |
2015-12-30 |
Sunshine Lake Pharma Co., Ltd. |
Compounds as hepatitis c virus (hcv) inhibitors and uses thereof in medicine
|
HUE046008T2
(hu)
|
2014-07-17 |
2020-02-28 |
Sunshine Lake Pharma Co Ltd |
I-(5-terc-butil)-izoxazol-3-il)-3-(4-((feniI)-etinil)-fenil)-kabamid származékok, valamint az ezekkel rokon vegyületek FLT-3 inhibitorokként rák kezelésére
|
JP6556146B2
(ja)
|
2014-08-26 |
2019-08-07 |
武田薬品工業株式会社 |
複素環化合物
|
GB201415573D0
(en)
|
2014-09-03 |
2014-10-15 |
Cancer Therapeutics Crc Pty Ltd |
Compounds
|
EP3188730B1
(en)
|
2014-09-05 |
2019-05-01 |
Merck Sharp & Dohme Corp. |
Tetrahydroisoquinoline derivatives useful as inhibitors of diacylglyceride o-acyltransferase 2
|
CN105461693B
(zh)
|
2014-09-26 |
2019-10-25 |
广东东阳光药业有限公司 |
Crth2拮抗剂化合物及其用途
|
EP3200779B1
(en)
|
2014-10-03 |
2022-03-23 |
Maheshwari, Divya |
Novel anthranilic acid derivatives
|
ES2578377B1
(es)
|
2014-12-22 |
2017-05-04 |
Consejo Superior De Investigaciones Científicas (Csic) |
Compuestos moduladores del sensor neuronal de calcio dream y sus usos terapéuticos.
|
KR20180005250A
(ko)
*
|
2015-05-21 |
2018-01-15 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
Pad4 억제제로서의 벤조이미다졸 유도체
|
EP4129278A1
(en)
|
2015-07-03 |
2023-02-08 |
Lars Klareskog |
Methods and compounds for the alleviation and/or prevention of bone loss and/or pain
|
WO2017024180A1
(en)
|
2015-08-06 |
2017-02-09 |
Amgen Inc. |
Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
EP3334736B1
(en)
|
2015-08-12 |
2023-06-28 |
Syngenta Participations AG |
Microbiocidal heterobicyclic derivatives
|
WO2017042182A1
(en)
|
2015-09-08 |
2017-03-16 |
F. Hoffmann-La Roche Ag |
Tricyclic pi3k inhibitor compounds and methods of use
|
MA47013A
(fr)
|
2015-10-21 |
2018-08-29 |
Otsuka Pharma Co Ltd |
Composés benzolactames utilisés en tant qu'inhibiteurs de protéine kinase
|
TW201726623A
(zh)
|
2015-12-17 |
2017-08-01 |
英塞特公司 |
作為免疫調節劑之雜環化合物
|
WO2017109095A1
(en)
|
2015-12-22 |
2017-06-29 |
AbbVie Deutschland GmbH & Co. KG |
Fused (hetero)cyclic compounds as s1p modulators
|
EP3190103A1
(en)
|
2016-01-08 |
2017-07-12 |
Rijksuniversiteit Groningen |
Inhibitors of the pd-1/pd-l1 protein/protein interaction
|
CA3015482A1
(en)
|
2016-02-23 |
2017-08-31 |
Padlock Therapeutics, Inc. |
Heteroaryl inhibitors of pad4
|
CN109476657A
(zh)
|
2016-06-16 |
2019-03-15 |
爱尔兰詹森科学公司 |
作为抗细菌剂的杂环化合物
|
PT3478662T
(pt)
|
2016-06-30 |
2020-12-09 |
Viiv Healthcare Uk No 5 Ltd |
Derivados de azadecalina como inibidores da replicação do vírus da imunodeficiência humana
|
WO2018019204A1
(zh)
|
2016-07-26 |
2018-02-01 |
深圳市塔吉瑞生物医药有限公司 |
用于抑制蛋白酪氨酸激酶活性的氨基嘧啶类化合物
|
AU2017305399A1
(en)
|
2016-08-03 |
2019-01-31 |
Arising International, Inc. |
Symmetric or semi-symmetric compounds useful as immunomodulators
|
TWI795381B
(zh)
|
2016-12-21 |
2023-03-11 |
比利時商健生藥品公司 |
作為malt1抑制劑之吡唑衍生物
|
WO2018112843A1
(en)
|
2016-12-22 |
2018-06-28 |
Merck Sharp & Dohme Corp. |
Heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor
|
WO2018121610A1
(zh)
|
2016-12-27 |
2018-07-05 |
山东大学 |
针对Smoothened突变株的刺猬通路抑制剂
|
CN107056630B
(zh)
|
2017-01-23 |
2020-01-17 |
合肥工业大学 |
一种茚满类衍生物及其合成方法和在医药上的用途
|
US12012467B2
(en)
|
2017-03-28 |
2024-06-18 |
Regents Of The University Of Michigan |
Small molecule DCN1 inhibitors and therapeutic methods using the same
|
EP3621962A4
(en)
|
2017-05-10 |
2020-12-09 |
Forge Therapeutics, Inc. |
ANTIBACTERIAL COMPOUNDS
|
CN107163044B
(zh)
|
2017-06-19 |
2021-04-23 |
广东药科大学 |
一类具有蛋白酶修饰活性的萘乙二酮化合物及其衍生物
|
JP2020524663A
(ja)
|
2017-06-21 |
2020-08-20 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
Irak4調節因子としてのイソインドリノン誘導体
|
GB201710851D0
(en)
|
2017-07-06 |
2017-08-23 |
Galápagos Nv |
Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis
|
EP3684767B1
(en)
|
2017-09-22 |
2024-04-24 |
Jubilant Epipad LLC |
Heterocyclic compounds as pad inhibitors
|
KR20200071752A
(ko)
|
2017-10-18 |
2020-06-19 |
주빌런트 에피파드 엘엘씨 |
Pad 억제제로서의 이미다조-피리딘 화합물
|
AU2018351651B2
(en)
|
2017-10-20 |
2023-01-05 |
Vanderbilt University |
Antagonists of the muscarinic acetylcholine receptor M4
|
US11629135B2
(en)
|
2017-11-06 |
2023-04-18 |
Jubilant Prodell Llc |
Pyrimidine derivatives as inhibitors of PD1/PD-L1 activation
|
SG11202004537UA
(en)
|
2017-11-24 |
2020-06-29 |
Jubilant Episcribe Llc |
Heterocyclic compounds as prmt5 inhibitors
|
US11420973B2
(en)
|
2017-12-19 |
2022-08-23 |
Bristol-Myers Squibb Company |
Amide substituted indole compounds useful as TLR inhibitors
|
CN110117278B
(zh)
|
2018-02-07 |
2022-07-19 |
石家庄以岭药业股份有限公司 |
烷氧基苯并五元(六元)杂环胺类化合物及其药物用途
|
KR102351458B1
(ko)
|
2018-02-14 |
2022-01-13 |
후지필름 가부시키가이샤 |
중합성 액정 조성물, 광학 이방성막, 광학 필름, 편광판 및 화상 표시 장치
|
JP7279063B6
(ja)
|
2018-03-13 |
2024-02-15 |
ジュビラント プローデル エルエルシー |
Pd1/pd-l1相互作用/活性化の阻害剤としての二環式化合物
|
JP6956033B2
(ja)
|
2018-03-14 |
2021-10-27 |
日本化薬株式会社 |
ベンゾアゾール化合物、並びにこれを含んだ顔料組成物
|
CN108358917B
(zh)
|
2018-04-24 |
2020-06-19 |
北京市结核病胸部肿瘤研究所 |
含有碱性稠环片段的咪唑并[1,2-a]吡啶-3-酰胺类化合物及其制备方法
|
CN112041296B
(zh)
|
2018-04-28 |
2023-12-29 |
上海璃道医药科技有限公司 |
包含苯并含氧脂肪环结构的氨基乙酰胺类化合物及其用途
|
WO2019213234A1
(en)
|
2018-05-01 |
2019-11-07 |
The Trustees Of Columbia University In The City Of New York |
Triazolopyrimidines, their preparation and use
|
EP3829575A4
(en)
|
2018-08-01 |
2022-07-20 |
The Trustees of Columbia University in the City of New York |
RBP4 ANTAGONISTS FOR THE TREATMENT AND PREVENTION OF NON-ALCOHOLIC LIVER DISEASE AND GOUT
|
EP3833664A4
(en)
|
2018-08-06 |
2022-06-08 |
Moexa Pharmaceuticals Limited |
SMAD3 INHIBITORS
|
WO2020045216A1
(ja)
|
2018-08-28 |
2020-03-05 |
富士フイルム株式会社 |
積層体および画像表示装置
|
CN110963997A
(zh)
|
2018-09-28 |
2020-04-07 |
四川科伦博泰生物医药股份有限公司 |
杂环酰胺类化合物、包含其的药物组合物及其制备方法和用途
|
EP3643711A1
(en)
|
2018-10-24 |
2020-04-29 |
Bayer Animal Health GmbH |
New anthelmintic compounds
|
KR102641718B1
(ko)
|
2018-10-30 |
2024-02-29 |
길리애드 사이언시즈, 인코포레이티드 |
알파4베타7 인테그린 억제제로서의 이미다조피리딘 유도체
|
CN110105299B
(zh)
|
2019-01-23 |
2023-01-03 |
中山大学 |
一种含芳醚取代恶唑烷酮羧酸酯类衍生物及其制备方法和应用
|
CN113905787A
(zh)
|
2019-04-05 |
2022-01-07 |
斯托姆治疗有限公司 |
Mettl3抑制化合物
|
RU2717101C1
(ru)
|
2019-06-03 |
2020-03-18 |
Андрей Александрович Иващенко |
Анелированные 9-гидрокси-1,8-диоксо-1,3,4,8-тетрагидро-2Н-пиридо[1,2-a]пиразин-7-карбоксамиды - ингибиторы интегразы ВИЧ, способы их получения и применения
|
JP7420502B2
(ja)
|
2019-07-24 |
2024-01-23 |
住友化学株式会社 |
重合性液晶混合組成物、位相差板、楕円偏光板および有機el表示装置
|
AR119494A1
(es)
|
2019-07-29 |
2021-12-22 |
Servier Lab |
DERIVADOS DE 6,7-DIHIDRO-5H-PIRIDO[2,3-c]PIRIDAZIN-8-ILO, COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN Y SUS USOS COMO AGENTES PROAPOPTÓTICOS
|
WO2021028810A1
(en)
|
2019-08-09 |
2021-02-18 |
Inorbit Therapeutics Ab |
Sulfinic acid compounds as free fatty acid receptor agonists
|
WO2021060432A1
(ja)
|
2019-09-27 |
2021-04-01 |
富士フイルム株式会社 |
液晶組成物、光学異方性層、光学フィルム、偏光板および画像表示装置
|
JP7182533B2
(ja)
|
2019-09-27 |
2022-12-02 |
富士フイルム株式会社 |
液晶組成物、光学異方性層、光学フィルム、偏光板および画像表示装置
|
CN114641477B
(zh)
|
2019-11-15 |
2024-03-12 |
柳韩洋行 |
对葡萄糖神经酰胺合酶具有抑制活性的化合物或其药学上可接受的盐和包含其的药物组合物
|
KR20210059632A
(ko)
|
2019-11-15 |
2021-05-25 |
주식회사유한양행 |
신규의 2,3-다이하이드로-1h-인덴 또는 2,3-다이하이드로벤조퓨란 모이어티를 갖는 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법, 및 이를 포함하는 약학 조성물
|
CN111606904B
(zh)
|
2020-04-07 |
2021-10-15 |
广州医科大学 |
氮杂吲哚类化合物及其应用
|